DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
Status:
Recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
To assess the effect of dapagliflozin compared with metolazone, added to furosemide, on
diuresis and decongestion in hospitalised heart failure patients with diuretic resistance,
and renal impairment. The primary analysis will be in patients with HFrEF but patients with
HFpEF will also be recruited in an ancillary study and included in supplementary analyses.